Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
12/20/2012 | US20120321708 Sustained-release formulations of topiramate |
12/20/2012 | US20120321705 Lineage Restricted Glial Precursors from the Central Nervous System |
12/20/2012 | US20120321704 Compound sea Cucumber Product, Preparation Method, and Dosage Forms Thereof |
12/20/2012 | US20120321694 Compositions and uses |
12/20/2012 | US20120321683 Liposome-Encapsulated Bicelles and Use Thereof in Diluted Systems |
12/20/2012 | US20120321678 Intra-articularly supplementation method for treating joint diseases and injuries |
12/20/2012 | US20120321672 Method of treating attention deficit hyperactivity disorder |
12/20/2012 | US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE |
12/20/2012 | US20120321644 Methods for diagnosing mood disorders |
12/20/2012 | US20120321621 INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS |
12/20/2012 | US20120321612 Systems and methods for treating post-operative, acute, and chronic pain using an intra-muscular catheter administrated combination of a local anesthetic and a neurotoxin protein |
12/20/2012 | US20120321610 Method to inhibit neuropathic pain by intrathecal injection of protein phosphatases |
12/20/2012 | US20120321609 Method of treating psychological disorders |
12/20/2012 | US20120321603 Composition and method for stabilization and delivery of therapeutic molecules |
12/20/2012 | US20120321602 Omega-3 fatty acid nutriceutical composition and optimization method |
12/20/2012 | US20120321599 Herpes virus strains |
12/20/2012 | US20120321594 Methods of controlling axon or dendrite development of neuronal cells |
12/20/2012 | US20120321590 Bridged polycyclic compounds |
12/20/2012 | US20120321559 Hexahydro-pyrrolo-isoquinoline compounds |
12/20/2012 | US20120321558 Compositions of high specific activity sn-117m and methods of preparing the same |
12/20/2012 | US20120321554 Plexin d1 as a target for tumor diagnosis and therapy |
12/20/2012 | US20120321553 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration |
12/20/2012 | CA2841416A1 Method of selecting therapeutic indications |
12/20/2012 | CA2837926A1 Scyllo - inositol for the treatment of behavioral and psychiatric disorders |
12/20/2012 | CA2836485A1 Bicyclo (3.1.0) hexane- 2 , 6 -dicarboxylic acid derivatives as mglu2 receptor agonist |
12/19/2012 | EP2535336A1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
12/19/2012 | EP2535335A1 Use of yessotoxin and analogues and derivatives thereof for treating and/or preventing neurodegenerative diseases linked to tau and beta amyloid |
12/19/2012 | EP2535059A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
12/19/2012 | EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
12/19/2012 | EP2535049A1 Tadalafil for the treatment of dementia |
12/19/2012 | EP2533795A2 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES |
12/19/2012 | EP2533787A1 Use of isorhamnetin triglycosides |
12/19/2012 | EP2533785A1 Treatment of loss of sense of touch with saxitoxin derivatives |
12/19/2012 | EP2533782A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS |
12/19/2012 | EP2533780A1 5-ht4 receptor agonists for the treatment of dementia |
12/19/2012 | EP2533774A2 Use of agomelatine for the preparation of drugs for treating obsessive compulsive disorder (ocd) |
12/19/2012 | EP2533645A1 Methods and compositions for improving cognitive function |
12/19/2012 | CN202605099U Moxibustion paster |
12/19/2012 | CN102834396A Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists |
12/19/2012 | CN102834384A Oxazine derivative |
12/19/2012 | CN102834380A Inhibitors of protein kinases |
12/19/2012 | CN102834118A Composition comprising the amyloid beta 1-6 peptide coupled to virus-like particle and an adjuvant |
12/19/2012 | CN102834107A Treatment of nerve injuries |
12/19/2012 | CN102834095A New therapeutic approaches for treating alzheimer disease |
12/19/2012 | CN102834093A Transdermally absorbed preparation of anti-dementia drug |
12/19/2012 | CN102834092A Transdermally absorbed preparation of anti-dementia drug |
12/19/2012 | CN102827256A Preparation and application of ginseng glycoprotein |
12/19/2012 | CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor |
12/19/2012 | CN102827131A Isoflavone carbamate compound, preparation method and applications of isoflavone carbamate compound |
12/19/2012 | CN102827081A Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor |
12/19/2012 | CN102827050A Methylene-thiosemicarbazone-based substituted phenoxy carboxylic acid derivative, and preparation method and application thereof |
12/19/2012 | CN102827049A (Thiosemicarbazideformyl) phenoxyacetic acid derivative and application thereof |
12/19/2012 | CN102824597A Application of anti-cerebral-thrombosis capsule for treating diseases in clinic as monoamine oxidase B inhibitor |
12/19/2012 | CN102824595A Traditional Chinese medicine composition for treating cancer ache |
12/19/2012 | CN102824560A Preparation method of traditional Chinese medicine lotion for treating closed fracture with syndrome of heart deficiency and timidity |
12/19/2012 | CN102824550A Method for preparing compound gastrodia elata preparation |
12/19/2012 | CN102824523A Method of preparing traditional Chinese medicine lotion for treating headache type closed fracture |
12/19/2012 | CN102824521A Application of longstamen onion bulb in preparing medicine used for treating depression |
12/19/2012 | CN102824510A Decoction medicine for treating phlegm-heat internal attacking type insomnia |
12/19/2012 | CN102824494A Medicine for treating nerve headache |
12/19/2012 | CN102824478A Decoction medicine for treating heart-spleen deficiency type insomnia |
12/19/2012 | CN102824470A Medicinal liquor for treating proplapse of lumbar intervertebral disc, ischialgia and leg pain |
12/19/2012 | CN102824469A Detoxification traditional Chinese medicine and preparation method thereof |
12/19/2012 | CN102824464A Method for preparing nine-flavor notopterygium granules |
12/19/2012 | CN102824453A Liquid having smoking cessation and health-care functions, and preparation method thereof |
12/19/2012 | CN102824447A Foot massaging solution agent for preventing and treating insomnia |
12/19/2012 | CN102824446A Medicinal composition with anti-fatigue effect as well as preparation method and application thereof |
12/19/2012 | CN102824442A Composition used for constitution of qi stagnation and preparation method and usage of composition |
12/19/2012 | CN102824439A Medicated wine capable of recuperating neurologic function |
12/19/2012 | CN102824438A Preparation method of Anle tablets |
12/19/2012 | CN102824429A External traditional Chinese medicine special for treating tubercular meningitis and preparation method thereof |
12/19/2012 | CN102824424A Preparation method of total saponin extract in irkutsk anemone rhizome |
12/19/2012 | CN102824401A External medicinal composition for askew animal oronasal caused by exogenous evil |
12/19/2012 | CN102824400A Composition containing eucommia ulmoides and teasel roots and application of composition for treating osteoporosis |
12/19/2012 | CN102824353A Helicid oral preparation, and preparation method and application thereof |
12/19/2012 | CN102824342A Compound used as antiepileptic medicine, and pharmaceutically acceptable salt thereof |
12/19/2012 | CN102824336A Application of (E)-2-(3,5-dimethoxybenzylidene)-cyclopentanone in preparing medicine for treating cerebrovascular diseases |
12/19/2012 | CN102824331A Zaleplon double-release capsule and preparation method thereof |
12/19/2012 | CN102824327A Medicinal composition of agomelatine-containing enteric-coated tablets |
12/19/2012 | CN102824317A New formulation containing bulleyaconitine A |
12/19/2012 | CN102824302A Topiramate sustained release preparation and preparation method thereof |
12/19/2012 | CN102823792A Soft propolis astragalus mongholicus capsule and preparation method thereof |
12/19/2012 | CN102228667B External medicinal plaster for treating facial paralysis and preparation method thereof |
12/19/2012 | CN102178678B Application of lycorine in preparing medicament for treating diseases caused by human enterovirus 71 type infection |
12/19/2012 | CN102058828B Medicinal composition and detection method for preparation thereof |
12/19/2012 | CN101987136B Medicine for treating neurodermatitis and preparation method thereof |
12/19/2012 | CN101984980B Extraction method, extract and pharmaceutical use of hypericum perforatum extract |
12/19/2012 | CN101910141B A novel alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
12/19/2012 | CN101790514B 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
12/19/2012 | CN101671554B Silica-coated fluorescent magnetic nanoparticle, preparation method and application |
12/19/2012 | CN101574341B Oral solid medicine composition containing ropinirole |
12/19/2012 | CN101538258B Compound of salvia miltiorrhiza and derivative, preparation method and medicine application thereof |
12/19/2012 | CN101129363B FK506 topical application sustained release film patch of immunosuppressive agent for accelerating regeneration of nerve, method of producing the same and use of the same |
12/19/2012 | CN101068794B Quinazolines useful as modulators of ion channels |
12/18/2012 | US8334289 Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor |
12/18/2012 | US8334263 Analgesic methods and compositions |
12/18/2012 | US8334262 Cognitive function |
12/18/2012 | US8333992 Gastric retained gabapentin dosage form |
12/18/2012 | US8333991 Gastric retained gabapentin dosage form |
12/18/2012 | US8333974 Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |